TCL1A Antibody

1. Combination of T-cell lymphoma-1 protein (TCL1)-overexpression and damaging ataxia telangiectasia mutated protein (ATM) functionally synergistically contribute to T-cell prolymphocytic leukemia (T-PLL) specific phenotype of impaired DNA damage processing. PMID: 29449575
2. Case Report: hematogones can express TCL-1 in patients with T-cell prolymphocytic leukemia after therapy. PMID: 28232160
3. TCL1A is not only a useful biomarker for prognostic evaluation in stage II/III colorectal cancer patients. PMID: 28178623
4. Our results suggest that intratumoral TCL1A+ B cells are important for controlling cervical cancer development. PMID: 26299617
5. Our study suggests that TCL1 expression profile may have a role in the prediction of overall outcome in patient with MCL and call for prospective studies. PMID: 25688912
6. We investigated TCL1 expression at the protein level in the bone marrow of a series of 59 patients with Waldenstrom macroglobulinemia: 76% of patients expressed TCL1, which appeared to be associated with a pejorative prognostic impact. PMID: 26493619
7. Suggest miR-181b as therapeutic target for chronic lymphocytic leukemia in the Emicro-TCL1 mouse model. PMID: 26090867
8. High TCL1A expression is associated with chronic lymphocytic leukemia. PMID: 25936528
9. Polymorphic genetic variations of cytochrome P450 19A1 and T-cell leukemia 1A genes in the Tamil population PMID: 25481307
10. Peptide-based TCL1-interphase mimics were potent in steric AKT antagonization. PMID: 25348018
11. demonstrated that miR-3676 targets three consecutive 28-bp repeats within 3'UTR of TCL1 and showed that miR-3676 is a powerful inhibitor of TCL1 PMID: 25646413
12. Case Report: T-cell lymphoblastic leukemia/lymphoma with t(7;14)(p15;q32) [TCRgamma-TCL1A translocation] confirmed by FISH. PMID: 24966976
13. Report frequent TCL1A rearrangements in T-cell prolymphocytic leukemia with cutaneous involvement. PMID: 25310835
14. TCL1-Tg:p53(-/-) leukemia cells exhibit higher survival capacity and are more drug resistant than the leukemia cells from TCL1-Tg:p53wt mice PMID: 23608884
15. TCL1A and ATM are co-expressed in chronic lymphocytic leukemia cells without deletion of 11q. PMID: 22875623
16. SNPs near the 3' terminus of TCL1A were associated with aromatase inhibitors-dependent musculoskeletal pain. Estradiol induced SNP-dependent TCL1A expression. PMID: 22405131
17. Data indicate that up-regulated transcription of TCL1A was observed in two cases. PMID: 22553924
18. Our findings reveal a functional interaction between Tcl1 and Hsp70 and identify Tcl1 as a novel Hsp70 client protein PMID: 23160471
19. Intracellular expression of the TCL1 as well as membrane and intracellular expression of ILT7 in plasmacytoid dendritic cell leukemia (pDCL) samples and 61 non-pDC acute leukemia samples, were tested. PMID: 22674796
20. These findings demonstrate that the microenvironment has a proactive role in the regulation of the known signaling enhancer and pro-survival molecule TCL1 in CLL. PMID: 22460735
21. TCL1 is hyperexpressed in multiple B-cell lymphomas. PMID: 22645177
22. 100% of dysgerminomas were positive for TCL1, but all immature teratomas were negative. PMID: 22448662
23. genetic association studies in a Japanese population: Data suggest that a substantial number of patients with T-cell prolymphocytic leukemia exhibit abnormal expression of TCL1A probably due to rearrangement in region of TCL1 gene. PMID: 22189846
24. CLL samples with high Tcl1 expression showed a decrease in DNA methylation compared with CLL samples with low Tcl1 expression PMID: 22308499
25. Using primary chronic lymphocytic leukemia cells we have shown an inverse relationship between TCL1 and PTPROt expression. PMID: 22001392
26. Data indicate an inverse correlation between miR-16-1, miR-181a, miR-181b, and level of expression of TCL-1 and BCL-2, which suggest that these miRNAs may implicate in negatively regulating target mRNA at transcriptional level. PMID: 21130495
27. This study identified 4 single nucleotide polymorphisms related to TCL1A that, when present, were associated with musculoskeletal adverse effects to anastrozole or exemestane treatment in postmenopausal women with stage I to III breast cancer. PMID: 21172079
28. TCL1 is a diagnostic marker for intratubular germ cell neoplasia and classic seminoma. PMID: 20553335
29. TCL1 positivity was predominantly found in germinal center phenotype diffuse large B-cell lymphoma. PMID: 20382409
30. CD5+CD23+ leukemic cell populations in TCL1 transgenic mice show significantly increased proliferation and Akt phosphorylation. PMID: 20357824
31. Immunohistochemical evaluation of TCL1 expression may be useful for substantiating a diagnosis of unclassified type of intratubular germ cell neoplasia or seminoma. PMID: 20395523
32. TCL1 mRNA expression may predict clinical outcome in CLL and that the IGHV3-21 subset, regardless of mutational status, displays high TCL1 expression. PMID: 19889012
33. establish that the association between TCL1A and IkappaB is compatible with AKT binding to TCL1A, but incompatible with IkappaB binding to NF-kappaB PMID: 19668332
34. An exposed hydrophobic patch composed of two discontinuous amino acid stretches has been identified near one end of the TCL1 beta-barrel that is required for TCL1-AKT binding association. PMID: 12009899
35. Increased TCL1 expression correlates with PBC-ALL progression and loss of TEL expression. TCL1 expression is important for the maturation of precursor lymphocytes but not differentiated B or T cells. PMID: 12127395
36. data demonstrate that TCL1 is a powerful oncogene that, when overexpressed in both B and T cells, predominantly yields mature B cell lymphomas PMID: 12381789
37. oncogene transactivation by Sp1 PMID: 12421830
38. results further support derivation of blastic tumors of skin from dendritic cells and demonstrate TCL1 proto-oncogene protein expression in this tumor PMID: 12576313
39. altered expression in Burkitt lymphomas in the presence of Epstein-Barr virus PMID: 12672960
40. Involved in the pathogenesis of mature leukemias and lymphomas: mature T-cell leukemia and chronic lymphocytic leukemia(review) PMID: 15325703
41. Akt kinase activity can be inhibited by a peptide spanning the betaA strand of the proto-oncogene TCL1 PMID: 15459205
42. Detailed mechanism for TCL1-augmented signaling helps explain the delayed occurrence of mature T cell expansions and leukemias despite tumorigenic TCL1 dysregulation that begins in early thymocytes. PMID: 16002684
43. In EBV-negative diffuse large B-cell lymphoma and Burkitt lymphoma-derived cell lines infected in vitro with a recombinant EBV, high expression of EBNA2 inversely correlated with expression of germinal center-associated genes, BCL6 and TCL1. PMID: 17151114
44. Expression levels of microRNA generally inversely correlated with Tcl1 expression in chronic lymphocytic leukemia. PMID: 17178851
45. Biological action of the proto-oncogene TCL1 family and the development avenues for a suppressive drug specific for Akt, a core intracellular survival regulator.[REVIEW] PMID: 17360849
46. TORC2 regulates germinal center repression of the TCL1 oncoprotein to promote B cell development and inhibit transformation. PMID: 17548807
47. TCL1 expression in B-cell tumors parallels its regulation in non-neoplastic B cells and can be used diagnostically as an indicator of the differentiation stage of a given B-cell tumor. PMID: 17592280
48. TCL1A deregulation may be caused by faulty gene silencing as a potential consequence of losses of 7q miRNAs in splenic marginal zone lymphoma. PMID: 17625607
49. Lower TCL-1 levels were associated with improved complete remission rate and progression-free survival PMID: 17659340
50. TCL1 inhibits activation-induced cell death in T cells by blocking PKCtheta and ERK activation, upon cellular activation PMID: 17846228

Show More

Hide All

HGNC: 11648

OMIM: 186960

KEGG: hsa:8115

STRING: 9606.ENSP00000385036

UniGene: Hs.2484